10:00 Chair’s opening remarks

James Halliwell, Editor, PRWeek

10:05 Panel discussion: How to create new, trusted narratives in healthcare comms
  • How data can help create trust and why a one-size-fits all approach won’t work
  • How can pharma comms professionals help teach the public how to identify fake news?
  • The value in addressing healthcare scepticism with compassion as a means to build inclusive working practises and trust in the profession

Danny Buckland, Journalist and Health Writer

Syeda Hasnain-Mohammed, Head of Communications, Kings Health Partners

Rose Williams, Senior Communications Manager, Boots UK

10:50 Diversity, equity and inclusion in pharma: your role in improving internal inclusivity
  • Why diversity remains a key challenge in the phamacomms profession and how you can tackle that through transparent and open communications
  • Addressing the need to diversify clinical trials and research to ensure results are relevant to wider groups of people
  • Recognising broader forms of diversity, like neurodiversity, and establishing your strategy to ensure all staff and patients have fair and equal access to your communications

Miguela Gonzales, Head of Diversity & Inclusion, Abcam

11:15 Networking break
11:50 Case study presentation: The benefits of building creativity into your pharma comms
  • Is there no room for creativity in pharma comms? Encouraging fresh perspectives and telling your story differently
  • How comedy helped Gilead breakdown the barrier of stigma to reach at-risk communities
  • Using a bold and empowering creative to unite culturally diverse communities

Rebecca Dandridge, Director of Public Affairs for HIV, Gilead Sciences

12:20 Virtual session: Hiding in plain sight: how to speak to the right audiences
  • How to segment the market for effective comms
  • Making sure the message comes from the right spokesman
  • Why you should always be translating your comms for different audiences

Marcia McKnight, Communications Lead, Kingston Council

12:45 Double fireside chat: Tackling pharma comms priorities for change in 2022 to stay ahead
  • How you can pave the way for positive change and champion new developments and technological advancements
  • Encouraging and facilitating collaboration and negotiation between private industry, NHS and government to improve healthcare overall
  • Advancing a faster decision-making process and supporting the move to more tailored, targeted treatments

Elliot Dunster, Executive Director, Corporate Affairs and Devolved Nations, APBI

Anthonia Aboyeji, Global Head of Communications, Human Pharma, Boehringer Ingelheim

13:15 Chair’s closing remarks & end of conference
13:20 Networking lunch

Speaking opportunities
Please contact Charli Veale on

Sponsorship and exhibition opportunities
Please contact Jess on +44 7584507938 or

General enquiries
Please call +44 (0)20 8267 4011 or email